Systematic review of smoking relapse rates among cancer survivors who quit at the time of cancer diagnosis
- PMID: 35988307
- PMCID: PMC10363369
- DOI: 10.1016/j.canep.2022.102237
Systematic review of smoking relapse rates among cancer survivors who quit at the time of cancer diagnosis
Abstract
Background: Tobacco cessation, at the time of cancer diagnosis, has been associated with better oncologic outcomes. Cancer diagnosis has been shown to serves as a "teachable moment," inspiring tobacco cessation. However, the sustainability of abstinence from smoking is understudied. Similarly, there is a paucity of data regarding the utility of behavioral/pharmacologic intervention to support continued smoking cessation.
Methods: A systematic literature review was conducted in August 2021 with no date limits. Relevant studies that reported tobacco smoking relapse rates for patients who quit at the time of cancer diagnosis were included. Our literature search identified 1620 articles and 29 met inclusion criteria. The primary endpoint of the study was smoking relapse rate. Secondary outcome was a descriptive assessment of behavioral and pharmacologic interventions to promote continued cessation. Exploratory outcomes included a regression analysis to examine associations between study factors and relapse rates.
Results: There were 3021 smokers who quit at the time of cancer diagnosis. Weighted overall relapse rate for the study population was 44 % (range 5-57 %). Interventions to support smoking cessation were employed in 17 of the 29 included studies and protocols were heterogenous, including behavioral, pharmacologic, or mixed intervention strategies. Exploratory analysis demonstrated no association between relapse rates and publication year, gender, or study type. Relapse rates were indirectly associated with age (p = .003), suggesting that younger patients were more likely to relapse.
Conclusion: The sustainability of smoking cessation after a cancer diagnosis is understudied, and existing literature is difficult to interpret due to heterogeneity. Relapse rates remain significant and, although many studies have included the employment of an intervention to promote continued cessation, few studies have measured the effect of a protocolized intervention to support abstinence.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Effectiveness of decision aids for smoking cessation in adults: a quantitative systematic review.JBI Database System Rev Implement Rep. 2018 Sep;16(9):1791-1822. doi: 10.11124/JBISRIR-2017-003698. JBI Database System Rev Implement Rep. 2018. PMID: 30204670
-
The State of the Science on Cancer Diagnosis as a "Teachable Moment" for Smoking Cessation: A Scoping Review.Nicotine Tob Res. 2022 Feb 1;24(2):160-168. doi: 10.1093/ntr/ntab139. Nicotine Tob Res. 2022. PMID: 34212198 Free PMC article.
-
A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder.J Dual Diagn. 2017 Jan-Mar;13(1):15-20. doi: 10.1080/15504263.2016.1267828. Epub 2016 Dec 5. J Dual Diagn. 2017. PMID: 27918881 Free PMC article.
-
Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit.J Cancer Surviv. 2019 Oct;13(5):687-694. doi: 10.1007/s11764-019-00787-5. Epub 2019 Jul 22. J Cancer Surviv. 2019. PMID: 31332721
-
HIV Care Initiation: A Teachable Moment for Smoking Cessation?Nicotine Tob Res. 2018 Aug 14;20(9):1109-1116. doi: 10.1093/ntr/ntx218. Nicotine Tob Res. 2018. PMID: 29059424 Free PMC article.
Cited by
-
Smoking cessation interventions in patients diagnosed with head and neck cancers: A systematic review of randomized controlled trials.Int J Health Sci (Qassim). 2023 Sep-Oct;17(5):45-53. Int J Health Sci (Qassim). 2023. PMID: 37692993 Free PMC article. Review.
-
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping Smoking.Asia Pac J Clin Oncol. 2025 Aug;21(4):368-376. doi: 10.1111/ajco.14153. Epub 2025 Feb 1. Asia Pac J Clin Oncol. 2025. PMID: 39891918 Free PMC article.
-
A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer.Support Care Cancer. 2024 Nov 29;32(12):836. doi: 10.1007/s00520-024-09030-z. Support Care Cancer. 2024. PMID: 39611967 Clinical Trial.
-
Perspectives on smoking cessation in the oncology environment: insights from brazilian patients and healthcare providers.Rev Bras Epidemiol. 2025 Aug 8;28:e250046. doi: 10.1590/1980-549720250046. eCollection 2025. Rev Bras Epidemiol. 2025. PMID: 40802346 Free PMC article.
-
Systematic Review of Smoking Cessation Interventions for Smokers Diagnosed with Cancer.Int J Environ Res Public Health. 2022 Dec 18;19(24):17010. doi: 10.3390/ijerph192417010. Int J Environ Res Public Health. 2022. PMID: 36554894 Free PMC article.
References
-
- Baser S, et al., Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest, 2006. 130(6): p. 1784–90. - PubMed
-
- Johnston-Early A, et al., Smoking abstinence and small cell lung cancer survival. An association. JAMA, 1980. 244(19): p. 2175–9. - PubMed
-
- Browman GP, et al., Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med, 1993. 328(3): p. 159–63. - PubMed
-
- Robinson CD, et al., Smoking cessation among men following cancer diagnosis: a matched cohort study. J Cancer Surviv, 2018. 12(6): p. 786–793. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous